Navigation Links
NIH to fund collaborations with industry to identify new uses for existing compounds
Date:6/18/2013

The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia. The collaborative pilot initiative, called Discovering New Therapeutic Uses for Existing Molecules, is led by the National Center for Advancing Translational Sciences (NCATS) and funded by the NIH Common Fund.

The process of developing a new therapeutic is long and difficult. The average length of time from target discovery to approval of a new drug is more than 13 years, and the failure rate exceeds 95 percent. This failure rate means, however, that many existing partially developed compounds could be advanced to clinical trials more quickly than starting from scratch.

"With thousands of diseases remaining untreatable, there is a sense of urgency to accelerate the pace at which discoveries are transformed into therapies for patients," said Health and Human Services Secretary Kathleen Sebelius. "This program helps forge partnerships between the pharmaceutical industry and the biomedical research community to work together to tackle problems that are beyond the scope of any one organization or sector."

"Innovative, collaborative approaches that improve the therapeutic pipeline are crucial for success," said NIH Director Francis S. Collins, M.D., Ph.D. "This unique collaboration between academia and industry holds the promise of trimming years from the long and expensive process of drug development."

AbbVie (formerly Abbott); AstraZeneca; Bristol-Myers Squibb Company; Eli Lilly and Company; GlaxoSmithKline; Janssen Research & Development, LLC; Pfizer; and Sanofi are participating in the pilot phase of the program.

NCATS launched this initiative in 2012 to help re-engineer the research pipeline using an innovative strategy to ident
'/>"/>

Contact: NCATS Office of Communications
ncatsinfo@mail.nih.gov
301-435-0888
NIH/National Center for Advancing Translational Sciences (NCATS)
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. NREL teams with Navy, private industry to make jet fuel from switchgrass
2. Maps developed to help forest industry outwit climate change
3. Governor Corbett Presented 2013 Biotechnology Industry Organization Governor of the Year Award
4. RAFT polymerization technology enabling the biotech industry
5. Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry
6. Evolution Marketing Research Grows its Practice with Addition of Three Key Industry Professionals
7. NREL employees lauded by industry peers
8. NREL assembles industry working group to advance solar securitization
9. Global Fingerprint Biometrics Industry
10. Global Hand Geometry Industry
11. Wake Forest Innovations Launches New Dot-Com Companies Offering Industry and Business Easy Access to Broad Range of Scientific Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2015)... IriTech, a leading iris based identity management ... Instruments Design Network, announced today that the Chief Minister ... USB MK2120U device during a launching event of Andhra ... The iris scanner is manufactured by U.S. ... India through its Indian partner, Biometronic ...
(Date:3/11/2015)... 2015   The Sync Project™ today ... measure and harness music to improve health. The ... objective measurements of physiology, enabling the study of ... large populations. It is designed for medical and ... rigorous studies and accelerate the discovery of the ...
(Date:3/5/2015)... -- In Brazil , cloud computing is ... solutions and 42 percent planning to invest in them by ... of the companies will be investing in these solutions for ... in the region are currently opting for the private cloud ... significant attention in the coming years. This trend is in ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
... available in Spanish . , Potatoes ... red, yellow, orange and purple flesh. This diversity also ... Prosser, Wash., are discovering. Together with colleagues, ... measuring phytonutrient concentrations in the tubers. Phytonutrients are plant ...
... waters are currently warmer than at any time in the ... colleagues report online in Nature Geoscience . ... a decline in the productivity of the lake, which hosts ... Africa depend on the fish from Lake Tanganyika as a ...
... The Genetics Society of America (GSA) will host ... Meeting, on June 12 to 15, 2010, in Boston, ... will bring together investigators who study genetic disease models ... other non-human organisms, combined with researchers in human genetics. ...
Cached Biology News:20th-century warming in Lake Tanganyika is unprecedented 220th-century warming in Lake Tanganyika is unprecedented 3Genetics Society of America to host Model Organisms to Human Biology Meeting, June 12-15, 2010 2Genetics Society of America to host Model Organisms to Human Biology Meeting, June 12-15, 2010 3
(Date:3/25/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... of recent discussions with certain shareholders representing approximately 45% ... after dealing with certain matters including the appointment of ... on March 26, 2015 (the "Meeting") it intends to ... will take place when the Meeting reconvenes. The Meeting ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... , CAMBRIDGE, Mass. and ... NextCODE, which provides comprehensive capabilities for using the genome to ... on their publication of the largest studies of whole-genome data ... online in Nature Genetics – are ... sequence variation, authored by a team of deCODE scientists led ...
(Date:3/25/2015)... CA (PRWEB) March 25, 2015 ... for Novel Mechanism of Action in Neuromuscular Diseases ... 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the ... skeletal muscle troponin activator tirasemtiv in the journal ... Phase IIa “Evidence of Effect” or hypothesis-generating clinical ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... on Monday announced a 20.3 percent increase in sales during ... production and shipment of its MRI monitor to its original ... the company said fourth-quarter net sales for fiscal 2005 were ... the same period of fiscal year 2004. , ,Fourth quarter ...
... I continue to be encouraged by the numerous positive signs ... are just a few: , ,& bull; The coming of ... ,& bull; The continued acquisition of Midwest biotech companies ... value of Midwest products and technology, the flip side of ...
... Madison, Wis. - Thomas R. Hefty has joined the ... Golden Angels Network, which closed a $535,000 seed investment in ... attorney with the Milwaukee-based law firm of Reinhart Boerner Van ... will step down from both positions while he is serving ...
Cached Biology Technology:Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4Hefty joins eMetagen board 2
... be able to handle larger sample volumes, automate ... as interface with telemetry systems. The AccuSampler ... dogs, pigs, and primates. The system may ... the computer can be located outside the animal ...
The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure su...
... A key to successful cell culture ... nutrient composition during the process, and make ... the composition. Nova BioProfile Chemistry Analyzers provide ... gases in cell culture and fermentation media. ...
... Testing Laboratory (RTL) can provide you ... years. ,,Microbial method development and validation ... the conditions of your GMP manufacturing ... products,,We offer a full spectrum of ...
Biology Products: